# Efficacy Study of the Effect of Budesonide on Emphysema

> **NCT00232674** · PHASE4 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 240 (—)

## Conditions studied

- Chronic Obstructive Pulmonary Disease

## Interventions

- **DRUG:** Pulmicort (budesonide) Turbuhaler

## Key facts

- **NCT ID:** NCT00232674
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-07
- **Primary completion:** —
- **Final completion:** 2004-02
- **Target enrollment:** 240 (—)
- **Last updated:** 2011-01-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00232674

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00232674, "Efficacy Study of the Effect of Budesonide on Emphysema". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00232674. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*